IBA Introduces QUASAR GRID3D Advantage for Advanced Image Distortion Analysis in Radiotherapy and Treatment Planning

IBA has launched QUASAR GRID3D Advantage, a 3D image distortion analysis system for MRI-guided radiotherapy and treatment planning simulation. The system uses automatic analysis and a multi-purpose solution with various adapters to ensure geometric fidelity of MRI images. The system is designed for installations requiring precise image distortion analysis, particularly in stereotactic planning. MRI is increasingly used in radiotherapy due to its ability to provide higher tissue contrast without ionizing radiation.

GE HealthCare (Nasdaq: GEHC) has announced plans to expand its radiation oncology portfolio and introduce new AI-enabled solutions at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria [1]. The company aims to enhance the oncology care workflow and improve patient outcomes by leveraging advanced technologies.

Key innovations include the integration of Spectronic Medical AB’s software offering into GE HealthCare's portfolio. Spectronic Medical, headquartered in Helsingborg, Sweden, specializes in advanced image analysis solutions designed to improve clinical workflows and enhance patient care in radiation oncology [1]. The MRI Planner software from Spectronic Medical, which is FDA 510(k) cleared and CE-marked, will enable MR-only radiotherapy workflows by converting standard MR images into synthetic CT images required for radiation treatment planning [1].

GE HealthCare also plans to introduce MR Contour DL™, an AI model that uses deep learning for organs at risk (OAR) segmentation. This model leverages the soft-tissue detail of MR images to create precise organ contours, bringing efficiency, consistency, and accuracy to radiation therapy treatment planning [1]. MR Contour DL will be integrated into GE HealthCare’s iRT digital solution for radiation therapy workflow management, reducing diagnostic time and workload.

Additionally, GE HealthCare will showcase its updated Intelligent Radiation Therapy (iRT) solution at ESTRO 2025. The latest version of iRT provides significant enhancements, including the ability to host and integrate third-party AI applications and embed MR imaging workflows. These new capabilities aim to enable a shorter timeline to treatment and improve the precision of radiation therapy [1].

The expansion of GE HealthCare's radiation oncology portfolio aligns with the global trend of increasing cancer cases and the need for more precise and personalized cancer care. The company's investments in AI and MR technologies reflect its commitment to advancing healthcare solutions and improving patient outcomes [1].

References:
[1] https://www.morningstar.com/news/business-wire/20250502364860/estro-2025-congress-ge-healthcare-to-expand-its-radiation-oncology-portfolio-and-introduce-new-ai-enabled-solutions